Global Nonalcoholic Steatohepatitis (NASH) Market Growth (Status and Outlook) 2022-2028
- LP 4871846
- 104 Pages
- February 2022
- Medical Devices
The United States Nonalcoholic Steatohepatitis (NASH) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nonalcoholic Steatohepatitis (NASH) market, reaching US$ million by the year 2028. As for the Europe Nonalcoholic Steatohepatitis (NASH) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nonalcoholic Steatohepatitis (NASH) players cover AstraZeneca, Arena Pharmaceuticals, GSK, and Novo Nordisk, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nonalcoholic Steatohepatitis (NASH) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Obeticholic acid（OCA）
Selonsertib
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Online Provider
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size 2017-2028
2.1.2 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Nonalcoholic Steatohepatitis (NASH) Segment by Type
2.2.1 Obeticholic acid（OCA）
2.2.2 Selonsertib
2.3 Nonalcoholic Steatohepatitis (NASH) Market Size by Type
2.3.1 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2022)
2.4 Nonalcoholic Steatohepatitis (NASH) Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Provider
2.4.3 Retail Pharmacy
2.5 Nonalcoholic Steatohepatitis (NASH) Market Size by Application
2.5.1 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2022)
3 Nonalcoholic Steatohepatitis (NASH) Market Size by Player
3.1 Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Players
3.1.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2020-2022)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Players (2020-2022)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nonalcoholic Steatohepatitis (NASH) by Regions
4.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (2017-2022)
4.2 Americas Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2017-2022)
4.3 APAC Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2017-2022)
4.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2017-2022)
4.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022)
5.2 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
5.3 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2017-2022)
6.2 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
6.3 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nonalcoholic Steatohepatitis (NASH) by Country (2017-2022)
7.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) by Region (2017-2022)
8.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022)
8.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.1 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Regions (2023-2028)
10.1.1 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Regions (2023-2028)
10.1.2 Americas Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.3 APAC Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.4 Europe Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Forecast
10.2 Americas Nonalcoholic Steatohepatitis (NASH) Forecast by Country (2023-2028)
10.2.1 United States Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.2 Canada Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.3 Mexico Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.4 Brazil Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3 APAC Nonalcoholic Steatohepatitis (NASH) Forecast by Region (2023-2028)
10.3.1 China Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.2 Japan Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.3 Korea Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.5 India Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.6 Australia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4 Europe Nonalcoholic Steatohepatitis (NASH) Forecast by Country (2023-2028)
10.4.1 Germany Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.2 France Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.3 UK Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.4 Italy Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.5 Russia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Forecast by Region (2023-2028)
10.5.1 Egypt Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.2 South Africa Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.3 Israel Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.4 Turkey Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.5 GCC Countries Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.6 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Type (2023-2028)
10.7 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Offered
11.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Arena Pharmaceuticals
11.2.1 Arena Pharmaceuticals Company Information
11.2.2 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Arena Pharmaceuticals Main Business Overview
11.2.5 Arena Pharmaceuticals Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Nonalcoholic Steatohepatitis (NASH) Product Offered
11.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Offered
11.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novo Nordisk Main Business Overview
11.4.5 Novo Nordisk Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Nonalcoholic Steatohepatitis (NASH) Product Offered
11.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Vivus
11.6.1 Vivus Company Information
11.6.2 Vivus Nonalcoholic Steatohepatitis (NASH) Product Offered
11.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Vivus Main Business Overview
11.6.5 Vivus Latest Developments
11.7 Arisaph Pharmaceuticals
11.7.1 Arisaph Pharmaceuticals Company Information
11.7.2 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Arisaph Pharmaceuticals Main Business Overview
11.7.5 Arisaph Pharmaceuticals Latest Developments
11.8 Cempra Pharmaceuticals
11.8.1 Cempra Pharmaceuticals Company Information
11.8.2 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Cempra Pharmaceuticals Main Business Overview
11.8.5 Cempra Pharmaceuticals Latest Developments
11.9 Galectin Therapeutics
11.9.1 Galectin Therapeutics Company Information
11.9.2 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Offered
11.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Galectin Therapeutics Main Business Overview
11.9.5 Galectin Therapeutics Latest Developments
11.10 Galmed Pharmaceuticals
11.10.1 Galmed Pharmaceuticals Company Information
11.10.2 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Galmed Pharmaceuticals Main Business Overview
11.10.5 Galmed Pharmaceuticals Latest Developments
11.11 Genfit
11.11.1 Genfit Company Information
11.11.2 Genfit Nonalcoholic Steatohepatitis (NASH) Product Offered
11.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Genfit Main Business Overview
11.11.5 Genfit Latest Developments
11.12 Gilead
11.12.1 Gilead Company Information
11.12.2 Gilead Nonalcoholic Steatohepatitis (NASH) Product Offered
11.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Gilead Main Business Overview
11.12.5 Gilead Latest Developments
12 Research Findings and Conclusion
Table 1. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Obeticholic acid（OCA）
Table 3. Major Players of Selonsertib
Table 4. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2022)
Table 7. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2022)
Table 10. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Player (2020-2022)
Table 12. Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Products Offered
Table 13. Nonalcoholic Steatohepatitis (NASH) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Regions (2017-2022)
Table 18. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country (2017-2022)
Table 20. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2022)
Table 22. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2022)
Table 24. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2017-2022)
Table 26. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2022)
Table 28. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2022)
Table 30. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country (2017-2022)
Table 32. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2022)
Table 34. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Nonalcoholic Steatohepatitis (NASH)
Table 43. Key Market Challenges & Risks of Nonalcoholic Steatohepatitis (NASH)
Table 44. Key Industry Trends of Nonalcoholic Steatohepatitis (NASH)
Table 45. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Application (2023-2028)
Table 51. AstraZeneca Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 52. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 53. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Arena Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 57. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 58. Arena Pharmaceuticals Main Business
Table 59. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Arena Pharmaceuticals Latest Developments
Table 61. GSK Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 62. GSK Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 63. GSK Main Business
Table 64. GSK Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. GSK Latest Developments
Table 66. Novo Nordisk Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 67. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 68. Novo Nordisk Main Business
Table 69. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Novo Nordisk Latest Developments
Table 71. Roche Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 72. Roche Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 73. Roche Main Business
Table 74. Roche Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Roche Latest Developments
Table 76. Vivus Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 77. Vivus Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 78. Vivus Main Business
Table 79. Vivus Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Vivus Latest Developments
Table 81. Arisaph Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 82. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 83. Arisaph Pharmaceuticals Main Business
Table 84. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Arisaph Pharmaceuticals Latest Developments
Table 86. Cempra Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 87. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 88. Cempra Pharmaceuticals Main Business
Table 89. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Cempra Pharmaceuticals Latest Developments
Table 91. Galectin Therapeutics Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 92. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 93. Galectin Therapeutics Main Business
Table 94. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Galectin Therapeutics Latest Developments
Table 96. Galmed Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 97. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 98. Galmed Pharmaceuticals Main Business
Table 99. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Galmed Pharmaceuticals Latest Developments
Table 101. Genfit Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 102. Genfit Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 103. Genfit Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Genfit Main Business
Table 105. Genfit Latest Developments
Table 106. Gilead Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 107. Gilead Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 108. Gilead Main Business
Table 109. Gilead Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Gilead Latest Developments
List of Figures
Figure 1. Nonalcoholic Steatohepatitis (NASH) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type in 2021
Figure 7. Nonalcoholic Steatohepatitis (NASH) in Hospital Pharmacy
Figure 8. Global Nonalcoholic Steatohepatitis (NASH) Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Nonalcoholic Steatohepatitis (NASH) in Online Provider
Figure 10. Global Nonalcoholic Steatohepatitis (NASH) Market: Online Provider (2017-2022) & ($ Millions)
Figure 11. Nonalcoholic Steatohepatitis (NASH) in Retail Pharmacy
Figure 12. Global Nonalcoholic Steatohepatitis (NASH) Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 13. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2021
Figure 14. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Player in 2021
Figure 15. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Nonalcoholic Steatohepatitis (NASH) Market Size 2017-2022 ($ Millions)
Figure 17. APAC Nonalcoholic Steatohepatitis (NASH) Market Size 2017-2022 ($ Millions)
Figure 18. Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2017-2022 ($ Millions)
Figure 20. Americas Nonalcoholic Steatohepatitis (NASH) Value Market Share by Country in 2021
Figure 21. Americas Nonalcoholic Steatohepatitis (NASH) Consumption Market Share by Type in 2021
Figure 22. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2021
Figure 23. United States Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region in 2021
Figure 28. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2021
Figure 29. China Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country in 2021
Figure 36. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type in 2021
Figure 37. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2021
Figure 38. Germany Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2021
Figure 46. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 52. APAC Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 53. Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 55. United States Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 56. Canada Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 59. China Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 60. Japan Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 61. Korea Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 63. India Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 64. Australia Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 65. Germany Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 66. France Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 67. UK Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 68. Italy Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 69. Russia Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 70. Spain Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 73. Israel Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Nonalcoholic Steatohepatitis (NASH) Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
